The global (-)-Trans-Caryophyllene market size was valued at US$ million in 2023. With growing demand in downstream market, the (-)-Trans-Caryophyllene is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global (-)-Trans-Caryophyllene market. (-)-Trans-Caryophyllene are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of (-)-Trans-Caryophyllene. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the (-)-Trans-Caryophyllene market.
(-)-Trans-Caryophyllene, a sesquiterpene, is the main constituent of the essential oils of Mentha longifolia and Commiphora gileadensis. It has anti-inflammatory, local anesthetic and antifungal properties. (-)-Trans-Caryophyllene also exhibited potent cytotoxic activity.Trans caryophyllene is another sesquiterpene that often appears in conjunction with beta-caryophyllene. It has similar medicinal properties to other terpenes but does not activate the endocannabinoid system. Peppery, spicy, sweet, or woodsy. Sesquiterpene that results from the oxidation of beta-caryophyllene. colorless to light yellow oily liquid. Molecular weight 204.36, boiling point 256 ℃(1.013 ×los Pa),118~121 ℃(1333Pa), relative density 0.9075, refractive index 1.5030. Insoluble in water, soluble in ethanol, with light clove odor. Natural products are found in clove oil, clove stem oil, Ceylon cinnamon oil, cinnamon leaf oil, lavender oil, thyme oil, pepper oil, pepper oil and other essential oils.
Key Features:
The report on (-)-Trans-Caryophyllene market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the (-)-Trans-Caryophyllene market. It may include historical data, market segmentation by Type (e.g., More Than 98%, More Than 98.5%), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the (-)-Trans-Caryophyllene market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the (-)-Trans-Caryophyllene market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the (-)-Trans-Caryophyllene industry. This include advancements in (-)-Trans-Caryophyllene technology, (-)-Trans-Caryophyllene new entrants, (-)-Trans-Caryophyllene new investment, and other innovations that are shaping the future of (-)-Trans-Caryophyllene.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the (-)-Trans-Caryophyllene market. It includes factors influencing customer ' purchasing decisions, preferences for (-)-Trans-Caryophyllene product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the (-)-Trans-Caryophyllene market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting (-)-Trans-Caryophyllene market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the (-)-Trans-Caryophyllene market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the (-)-Trans-Caryophyllene industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the (-)-Trans-Caryophyllene market.
Market Segmentation:
(-)-Trans-Caryophyllene market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
More Than 98%
More Than 98.5%
Others
Segmentation by application
Experimental Research
Biomedicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Sigma-Aldrich
MP Biomedicals
Santa Cruz Biotechnology
BioCrick
Supelco
Toronto Research Chemicals
National Analytical Corporation
ChemFaces
Extrasynthese
Purisys
Axios
Wen Xi Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global (-)-Trans-Caryophyllene market?
What factors are driving (-)-Trans-Caryophyllene market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do (-)-Trans-Caryophyllene market opportunities vary by end market size?
How does (-)-Trans-Caryophyllene break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global (-)-Trans-Caryophyllene Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for (-)-Trans-Caryophyllene by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for (-)-Trans-Caryophyllene by Country/Region, 2019, 2023 & 2030
2.2 (-)-Trans-Caryophyllene Segment by Type
2.2.1 More Than 98%
2.2.2 More Than 98.5%
2.2.3 Others
2.3 (-)-Trans-Caryophyllene Sales by Type
2.3.1 Global (-)-Trans-Caryophyllene Sales Market Share by Type (2019-2024)
2.3.2 Global (-)-Trans-Caryophyllene Revenue and Market Share by Type (2019-2024)
2.3.3 Global (-)-Trans-Caryophyllene Sale Price by Type (2019-2024)
2.4 (-)-Trans-Caryophyllene Segment by Application
2.4.1 Experimental Research
2.4.2 Biomedicine
2.4.3 Others
2.5 (-)-Trans-Caryophyllene Sales by Application
2.5.1 Global (-)-Trans-Caryophyllene Sale Market Share by Application (2019-2024)
2.5.2 Global (-)-Trans-Caryophyllene Revenue and Market Share by Application (2019-2024)
2.5.3 Global (-)-Trans-Caryophyllene Sale Price by Application (2019-2024)
3 Global (-)-Trans-Caryophyllene by Company
3.1 Global (-)-Trans-Caryophyllene Breakdown Data by Company
3.1.1 Global (-)-Trans-Caryophyllene Annual Sales by Company (2019-2024)
3.1.2 Global (-)-Trans-Caryophyllene Sales Market Share by Company (2019-2024)
3.2 Global (-)-Trans-Caryophyllene Annual Revenue by Company (2019-2024)
3.2.1 Global (-)-Trans-Caryophyllene Revenue by Company (2019-2024)
3.2.2 Global (-)-Trans-Caryophyllene Revenue Market Share by Company (2019-2024)
3.3 Global (-)-Trans-Caryophyllene Sale Price by Company
3.4 Key Manufacturers (-)-Trans-Caryophyllene Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers (-)-Trans-Caryophyllene Product Location Distribution
3.4.2 Players (-)-Trans-Caryophyllene Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for (-)-Trans-Caryophyllene by Geographic Region
4.1 World Historic (-)-Trans-Caryophyllene Market Size by Geographic Region (2019-2024)
4.1.1 Global (-)-Trans-Caryophyllene Annual Sales by Geographic Region (2019-2024)
4.1.2 Global (-)-Trans-Caryophyllene Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic (-)-Trans-Caryophyllene Market Size by Country/Region (2019-2024)
4.2.1 Global (-)-Trans-Caryophyllene Annual Sales by Country/Region (2019-2024)
4.2.2 Global (-)-Trans-Caryophyllene Annual Revenue by Country/Region (2019-2024)
4.3 Americas (-)-Trans-Caryophyllene Sales Growth
4.4 APAC (-)-Trans-Caryophyllene Sales Growth
4.5 Europe (-)-Trans-Caryophyllene Sales Growth
4.6 Middle East & Africa (-)-Trans-Caryophyllene Sales Growth
5 Americas
5.1 Americas (-)-Trans-Caryophyllene Sales by Country
5.1.1 Americas (-)-Trans-Caryophyllene Sales by Country (2019-2024)
5.1.2 Americas (-)-Trans-Caryophyllene Revenue by Country (2019-2024)
5.2 Americas (-)-Trans-Caryophyllene Sales by Type
5.3 Americas (-)-Trans-Caryophyllene Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC (-)-Trans-Caryophyllene Sales by Region
6.1.1 APAC (-)-Trans-Caryophyllene Sales by Region (2019-2024)
6.1.2 APAC (-)-Trans-Caryophyllene Revenue by Region (2019-2024)
6.2 APAC (-)-Trans-Caryophyllene Sales by Type
6.3 APAC (-)-Trans-Caryophyllene Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe (-)-Trans-Caryophyllene by Country
7.1.1 Europe (-)-Trans-Caryophyllene Sales by Country (2019-2024)
7.1.2 Europe (-)-Trans-Caryophyllene Revenue by Country (2019-2024)
7.2 Europe (-)-Trans-Caryophyllene Sales by Type
7.3 Europe (-)-Trans-Caryophyllene Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa (-)-Trans-Caryophyllene by Country
8.1.1 Middle East & Africa (-)-Trans-Caryophyllene Sales by Country (2019-2024)
8.1.2 Middle East & Africa (-)-Trans-Caryophyllene Revenue by Country (2019-2024)
8.2 Middle East & Africa (-)-Trans-Caryophyllene Sales by Type
8.3 Middle East & Africa (-)-Trans-Caryophyllene Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of (-)-Trans-Caryophyllene
10.3 Manufacturing Process Analysis of (-)-Trans-Caryophyllene
10.4 Industry Chain Structure of (-)-Trans-Caryophyllene
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 (-)-Trans-Caryophyllene Distributors
11.3 (-)-Trans-Caryophyllene Customer
12 World Forecast Review for (-)-Trans-Caryophyllene by Geographic Region
12.1 Global (-)-Trans-Caryophyllene Market Size Forecast by Region
12.1.1 Global (-)-Trans-Caryophyllene Forecast by Region (2025-2030)
12.1.2 Global (-)-Trans-Caryophyllene Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global (-)-Trans-Caryophyllene Forecast by Type
12.7 Global (-)-Trans-Caryophyllene Forecast by Application
13 Key Players Analysis
13.1 Sigma-Aldrich
13.1.1 Sigma-Aldrich Company Information
13.1.2 Sigma-Aldrich (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.1.3 Sigma-Aldrich (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Sigma-Aldrich Main Business Overview
13.1.5 Sigma-Aldrich Latest Developments
13.2 MP Biomedicals
13.2.1 MP Biomedicals Company Information
13.2.2 MP Biomedicals (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.2.3 MP Biomedicals (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 MP Biomedicals Main Business Overview
13.2.5 MP Biomedicals Latest Developments
13.3 Santa Cruz Biotechnology
13.3.1 Santa Cruz Biotechnology Company Information
13.3.2 Santa Cruz Biotechnology (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.3.3 Santa Cruz Biotechnology (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Santa Cruz Biotechnology Main Business Overview
13.3.5 Santa Cruz Biotechnology Latest Developments
13.4 BioCrick
13.4.1 BioCrick Company Information
13.4.2 BioCrick (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.4.3 BioCrick (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 BioCrick Main Business Overview
13.4.5 BioCrick Latest Developments
13.5 Supelco
13.5.1 Supelco Company Information
13.5.2 Supelco (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.5.3 Supelco (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Supelco Main Business Overview
13.5.5 Supelco Latest Developments
13.6 Toronto Research Chemicals
13.6.1 Toronto Research Chemicals Company Information
13.6.2 Toronto Research Chemicals (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.6.3 Toronto Research Chemicals (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Toronto Research Chemicals Main Business Overview
13.6.5 Toronto Research Chemicals Latest Developments
13.7 National Analytical Corporation
13.7.1 National Analytical Corporation Company Information
13.7.2 National Analytical Corporation (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.7.3 National Analytical Corporation (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 National Analytical Corporation Main Business Overview
13.7.5 National Analytical Corporation Latest Developments
13.8 ChemFaces
13.8.1 ChemFaces Company Information
13.8.2 ChemFaces (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.8.3 ChemFaces (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 ChemFaces Main Business Overview
13.8.5 ChemFaces Latest Developments
13.9 Extrasynthese
13.9.1 Extrasynthese Company Information
13.9.2 Extrasynthese (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.9.3 Extrasynthese (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Extrasynthese Main Business Overview
13.9.5 Extrasynthese Latest Developments
13.10 Purisys
13.10.1 Purisys Company Information
13.10.2 Purisys (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.10.3 Purisys (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Purisys Main Business Overview
13.10.5 Purisys Latest Developments
13.11 Axios
13.11.1 Axios Company Information
13.11.2 Axios (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.11.3 Axios (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Axios Main Business Overview
13.11.5 Axios Latest Developments
13.12 Wen Xi Pharma
13.12.1 Wen Xi Pharma Company Information
13.12.2 Wen Xi Pharma (-)-Trans-Caryophyllene Product Portfolios and Specifications
13.12.3 Wen Xi Pharma (-)-Trans-Caryophyllene Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Wen Xi Pharma Main Business Overview
13.12.5 Wen Xi Pharma Latest Developments
14 Research Findings and Conclusion
Ìý
Ìý
*If Applicable.
